Henry Bergman

Henry Bergman

Auto-generated profile, based on publicly available information

Henry Bergman

Clinical AI Research, Heidi Health, 140 Goswell Road, London EC1V 7DY, United Kingdom

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
BCBenjamin Clay
Benjamin Clay
HBHenry I. Bergman
Henry I. Bergman
SSSafa Salim
Safa Salim
GPGabriele Pergola
Gabriele Pergola
JSJoseph Shalhoub
Joseph Shalhoub
ADAlun Huw Davies
Alun Huw Davies
Natural Language Processing (NLP) has the potential to revolutionise clinical research utilising Electronic Health Records (EHR) through the automated analysis of unstructured free text. Despite this potential, relatively few applications have entered real-world clinical practice. This paper aims to introduce the whole pipeline of NLP methodologies for EHR analysis to the clinical researcher, with case studies to demonstrate the application of these methods in the existing literature. Essential pre-processing steps are introduced, followed by the two major classes of analytical frameworks: statistical methods and Artificial Neural Networks (ANNs). Case studies which apply statistical and ANN-based methods are then provided and discussed, illustrating information extraction tasks for objective and subjective information, and classification/prediction tasks using supervised and unsupervised approaches. State-of-the-art large language models and future directions for research are then discussed. This educational article aims to bridge the gap between the clinical researcher and the NLP expert, providing clinicians with a background understanding of the NLP techniques relevant to EHR analysis, allowing engagement with this rapidly evolving area of research, which is likely to have a major impact on clinical practice in coming years.

1 January 2024 in Journal of Vascular Societies Great Britain & Ireland
Verified
Journal Article
Closed access
HBH Bergman
H Bergman
BCB Clay
B Clay
TLT Lane
T Lane

4 December 2023 in Journal of Endovascular Therapy
Verified
Journal Article
Open access
MMMervyn McKenna
Mervyn McKenna
HEHussein Elghazaly
Hussein Elghazaly
HBHenry Bergman
Henry Bergman
LWLaura Wingate
Laura Wingate
DRDan Robbins
Dan Robbins
ATAnkur Thapar
Ankur Thapar
Introduction: The aim of this systematic review was to identify the evidence in the literature for limb salvage with the introduction of duplex surveillance. Methods: A systematic review and meta-analysis was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA) methodology for all studies which compared a group undergoing clinical surveillance with a group undergoing combined clinical and duplex surveillance after endovascular therapy for peripheral arterial disease. MEDLINE, EMBASE, the Cochrane Database for Systematic Reviews, and ClinicalTrials.gov were searched for relevant studies by 2 reviewers. Studies were quality assessed using the ROBINS-I tool. An individual patient data survival analysis and meta-analysis for 1- and 2-year amputation outcomes using a random-effects model were performed. Results: Two low-quality nonrandomized studies met the inclusion criteria. There was a statistically and clinically significant reduction in major amputation in patients undergoing combined clinical and duplex surveillance (log-rank p<0.001). The number needed to treat to prevent 1 amputation at 2 years was 5 patients. At 1 year, the odds ratio (OR) for amputation was 0.22, 95% confidence interval (CI)=0.10-0.48, with no statistical heterogeneity. At 2 years, the numbers of patients were low and the effect on amputation was less certain OR=0.25, 95% CI=0.04-1.58. Conclusions: Preliminary, low-quality data suggests that there may be a clinically significant reduction in major amputation with the introduction of duplex surveillance. It is recommended that a randomized controlled trial is performed to confirm these findings and identify the anatomical subgroups that benefit the most from surveillance. Clinical Impact: “Two low-quality studies reveal a significant clinical impact: combined clinical and duplex surveillance markedly reduces major amputations (log-rank p<0.001). At 1-year, the odds ratio for amputation is 0.22 (95% CI=0.10-0.48), emphasizing limb salvage benefits. Despite less certainty at 2-years, a notable absolute risk reduction of 19% is seen, with a number needed to treat of 5. This underscores the urgent need for a randomized controlled trial to validate findings and identify key subgroups. The meta-analysis strongly advocates implementing duplex surveillance for a year post-endovascular interventions, especially in patients fit for reintervention, with important considerations for cost-effectiveness and focused clinical trials.”

21 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
HBHenry I Bergman
Henry I Bergman
HEHussein Elghazaly
Hussein Elghazaly
ATAnkur Thapar
Ankur Thapar
ADAlun H. Davies
Alun H. Davies
Background Despite significant improvements in endovascular technology and anaesthetic practice over the last 20 years, patients with CLTI remain at high risk of major limb amputation and overall mortality. The aim of this systematic review was to provide a contemporary review of the rate of major amputation and key clinical outcomes following all endovascular interventions in CLTI. Methods A systematic review and meta-analysis of prospective studies from 2010-2020 reporting the risk of major lower limb amputation in patients with CLTI. MEDLINE, EMBASE, the Cochrane Database for Systematic Reviews and ClinicalTrials.gov were searched for relevant studies by 2 reviewers. The primary endpoint was rate of major limb amputation at 1 year and 2 years. Meta-analysis of proportions was employed using the random effects model. Studies were quality assessed using the ROBINS-I tool. To investigate factors associated with major limb amputations, subgroup analyses and meta-regression for clinical-demographic and lesion characteristics were employed. Results A total of 28 studies, from 24 manuscripts were eligible for inclusion. These included a total of 49,756 patients. At one-year post-revascularisation, the pooled rate of major lower limb amputations at 1 year was 8.6% (95% CI 6.7% - 11.0%). At two years, the rate of major amputations was 11.1% (95% CI 7.6% - 16.0%). Subgroup analysis showed that in studies that mandated stent deployment for all patients, there was a significantly lower rate of major amputations of 5.1% (95% CI 4.7% - 5.5%). Meta-regression showed that none of the clinical-demographic and lesion characteristics were associated with major lower limb amputations, and no volume-outcome relationship was observed. Conclusions This review provides important benchmarking information on the outcomes of endovascular intervention in a frail CLTI cohort. This provides a realistic evaluation of risk to facilitate full informed consent and the setting of realistic expectations regarding the need for reintervention, major and minor amputation and overall mortality.

21 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
HBHenry Bergman
Henry Bergman
VLVivian Liu
Vivian Liu
BABen Austin
Ben Austin
SASarah Ali
Sarah Ali
ETElliot Taylor
Elliot Taylor
FVFerdinand Vermersch
Ferdinand Vermersch
Background: Ambient AI documentation tools (“scribes”) are entering routine clinical practice at scale, but the evidence comparing the notes they produce against clinician-written notes is dominated by single-site, single-language studies that rely on human review to find errors — a method known to miss most documentation errors. Methods: We conducted a paired simulation across five countries and languages (Cambridge/English, Barcelona/Spanish, Milan/Italian, Paris/French, Cologne/German; 385 paired consultations, 770 notes). From each actor-performed consultation, an AI scribe (Heidi) and a junior-to-middle-grade clinician independently produced a note. Notes were scored on the PDQI-9 by evaluators blinded to authorship. Documentation errors were identified by two methods of deliberately different sensitivity — clinician adjudication, and a calibrated automated reviewer externally validated against a blinded ten-clinician panel — then graded for clinical risk by a three-model panel. The co-primary outcomes were PDQI-9 total and Critical+High error burden, the latter reported under both detection arms. The analysis plan was registered before any pooling across sites. Results: AI notes scored higher than clinician notes on the PDQI-9 (40.6 vs 35.6; difference +5.08, 95% CI 4.6–5.6; Cohen’s dz=0.55), consistently across all five sites (dz 0.41–0.75), and were less dispersed (5.7% of AI vs 27.8% of clinician notes fell below the study pre-specified low-score threshold (<32)). On the principal safety outcome — the paired probability that a note carried ≥1 Critical+High error — clinician notes were affected more often under both detection arms: 61.0% versus 24.4% by the calibrated reviewer (relative risk 2.50, 95% CI 2.09–3.00) and 21.8% versus 6.2% by clinician adjudication (relative risk 3.50, 95% CI 2.32–5.27). The difference was largest for omissions. Unaided clinician review identified roughly 12% of the errors the calibrated reviewer retained, and a smaller fraction in AI notes than in clinician notes. Conclusions: In this simulation, AI-generated notes scored higher on documentation quality, varied less, and carried fewer clinically significant errors than notes written on the same consultations by junior-to-middle-grade clinicians. The magnitude of the safety difference depends on the sensitivity of error detection, so we report both detection regimes and bound rather than point-estimate the absolute error rate. Extension to live practice, consultant-authored documentation, and notes as filed after clinician editing remains to be established. One sentence description: In a five-country, five-language paired simulation, AI-generated clinical notes scored higher on documentation quality and carried fewer clinically significant errors than notes written on the same consultations by junior-to-middle-grade clinicians.

14 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
HBHenry Bergman
Henry Bergman
VLVivian Liu
Vivian Liu
BABen Austin
Ben Austin
RSRohan Sanghera
Rohan Sanghera
Objective Ambient AI scribes evaluated using frequency-based metrics such as word error rate (WER), which do not represent clinical consequence. We tested whether variation in these metrics tracks consequential transcription errors. Methods We constructed a multilingual corpus from five clinical dictation scripts spanning a complexity gradient, translated into 99 languages, rendered to synthetic speech under three acoustic conditions, and transcribed by a production ambient scribe. Six frequency metrics were computed. Three independent large language model raters from external providers assessed clinically meaningful error patterns in context using a Severity x Likelihood framework informed by UK digital clinical-safety-risk-management principles. Results Across 59,819 genuine transcription-error occurrences, 58,329 (97.5%) were LOW risk and 251 (0.42%) CRITICAL or HIGH. None of six frequency metrics showed a statistically detectable association with serious clinical risk across languages; correlations were small (absolute Spearman ρ<0.16). A Severity x Likelihood sum remained strongly correlated with WER (ρ=0.80), showing that the aggregate remained dominated by benign errors. At complexity level 3, low-resource languages had worse WER than high-resource languages (β=+0.078, 95% CI +0.045 to +0.111; p<0.0001), without a detectable difference in CRITICAL/HIGH risk (OR 1.21, 95% CI 0.43 to 3.43; p=0.72). Consultation complexity was the principal predictor of serious risk (OR 3.06 per level, p<0.0001). Conclusion Across this controlled multilingual corpus, aggregate transcription-frequency metrics did not reliably track the sparse severe tail of clinically consequential errors. WER remains appropriate for transcription quality, but these data do not support its use alone as a proxy for clinical safety. Context-aware assessment of error consequence provides complementary information that frequency measures can dilute.